AI Summary
Anti-platelet therapy may benefit patients with aneurysmal subarachnoid hemorrhage, a fatal type of brain bleed.
A new study has shown that anti-platelet therapy could help improve outcomes for patients with aneurysmal subarachnoid hemorrhage (aSAH), a deadly form of brain bleed.